Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activation

被引:128
作者
Eng, Jason W. -L. [1 ]
Reed, Chelsey B. [1 ]
Kokolus, Kathleen M. [1 ]
Pitoniak, Rosemarie [1 ]
Utley, Adam [1 ]
Bucsek, Mark J. [1 ]
Ma, Wen Wee [2 ]
Repasky, Elizabeth A. [1 ]
Hylander, Bonnie L. [1 ]
机构
[1] Roswell Pk Canc Inst, Ctr Genet & Pharmacol, Dept Immunol, Buffalo, NY 14263 USA
[2] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA
关键词
PANCREATIC-CANCER CELLS; BETA-BLOCKER USAGE; BREAST-CANCER; LABORATORY MICE; DEPENDENT ACTIVATION; GROWTH-REGULATION; SOCIAL-ISOLATION; COLD STRESS; KAPPA-B; NOREPINEPHRINE;
D O I
10.1038/ncomms7426
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cancer research relies heavily on murine models for evaluating the anti-tumour efficacy of therapies. Here we show that the sensitivity of several pancreatic tumour models to cytotoxic therapies is significantly increased when mice are housed at a thermoneutral ambient temperature of 30 degrees C compared with the standard temperature of 22 degrees C. Further, we find that baseline levels of norepinephrine as well as the levels of several anti-apoptotic molecules are elevated in tumours from mice housed at 22 degrees C. The sensitivity of tumours to cytotoxic therapies is also enhanced by administering a beta-adrenergic receptor antagonist to mice housed at 22 degrees C. These data demonstrate that standard housing causes a degree of cold stress sufficient to impact the signalling pathways related to tumour-cell survival and affect the outcome of pre-clinical experiments. Furthermore, these data highlight the significant role of host physiological factors in regulating the sensitivity of tumours to therapy.
引用
收藏
页数:13
相关论文
共 70 条
[1]  
[Anonymous], 2011, COMM UPD GUID CAR US
[2]   Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy [J].
Apetoh, Lionel ;
Ghiringhelli, Francois ;
Tesniere, Antoine ;
Obeid, Michel ;
Ortiz, Carla ;
Criollo, Alfredo ;
Mignot, Gregoire ;
Maiuri, M. Chiara ;
Ullrich, Evelyn ;
Saulnier, Patrick ;
Yang, Huan ;
Amigorena, Sebastian ;
Ryffel, Bernard ;
Barrat, Franck J. ;
Saftig, Paul ;
Levi, Francis ;
Lidereau, Rosette ;
Nogues, Catherine ;
Mira, Jean-Paul ;
Chompret, Agnes ;
Joulin, Virginie ;
Clavel-Chapelon, Francoise ;
Bourhis, Jean ;
Andre, Fabrice ;
Delaloge, Suzette ;
Tursz, Thomas ;
Kroemer, Guido ;
Zitvogel, Laurence .
NATURE MEDICINE, 2007, 13 (09) :1050-1059
[3]   Src activation by β-adrenoreceptors is a key switch for tumour metastasis [J].
Armaiz-Pena, Guillermo N. ;
Allen, Julie K. ;
Cruz, Anthony ;
Stone, Rebecca L. ;
Nick, Alpa M. ;
Lin, Yvonne G. ;
Han, Liz Y. ;
Mangala, Lingegowda S. ;
Villares, Gabriel J. ;
Vivas-Mejia, Pablo ;
Rodriguez-Aguayo, Cristian ;
Nagaraja, Archana S. ;
Gharpure, Kshipra M. ;
Wu, Zheng ;
English, Robert D. ;
Soman, Kizhake V. ;
Shazhad, Mian M. K. ;
Zigler, Maya ;
Deavers, Michael T. ;
Zien, Alexander ;
Soldatos, Theodoros G. ;
Jackson, David B. ;
Wiktorowicz, John E. ;
Torres-Lugo, Madeline ;
Young, Tom ;
De Geest, Koen ;
Gallick, Gary E. ;
Bar-Eli, Menashe ;
Lopez-Berestein, Gabriel ;
Cole, Steve W. ;
Lopez, Gustavo E. ;
Lutgendorf, Susan K. ;
Sood, Anil K. .
NATURE COMMUNICATIONS, 2013, 4
[4]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[5]   Ligand-based targeting of apoptosis in cancer: The potential of recombinant human apoptosis ligand 2/tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL) [J].
Ashkenazi, Avi ;
Holland, Pamela ;
Eckhardt, S. Gail .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) :3621-3630
[6]   Directing cancer cells to self-destruct with pro-apoptotic receptor agonists [J].
Ashkenazi, Avi .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (12) :1001-1012
[7]   Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer [J].
Awasthi, Niranjan ;
Zhang, Changhua ;
Schwarz, Anna M. ;
Hinz, Stefan ;
Wang, Changguang ;
Williams, Noelle S. ;
Schwarz, Margaret A. ;
Schwarz, Roderich E. .
CARCINOGENESIS, 2013, 34 (10) :2361-2369
[8]   Beta Blockers and Breast Cancer Mortality: A Population-Based Study [J].
Barron, Thomas I. ;
Connolly, Roisin M. ;
Sharp, Linda ;
Bennett, Kathleen ;
Visvanathan, Kala .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (19) :2635-2644
[9]   Overexpression of Glucocorticoid Receptor in Human Pancreatic Cancer and in Xenografts. An Immunohistochemical Study [J].
Bekasi, Sandor ;
Zalatnai, Attila .
PATHOLOGY & ONCOLOGY RESEARCH, 2009, 15 (04) :561-566
[10]  
Buttles S. S., EUR J CANC, V31, P408